Has Covid-19 impacted access to Parkinson’s medication?

News

Author: Simge Eva DoganPublished: 17 September 2020

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

New research has found that the coronavirus pandemic has affected access to medication for people living with Parkinson’s disease.

The sub-study used information from a survey conducted by the International Parkinson and Movement Disorder Society. The results from 346 participants showed that 22.8% of high-income and 88.9% of low-income countries’ respondents agreed that the coronavirus crisis had impacted people’s access to Parkinson’s medication. Some respondents reported increased disability, increased hospitalisation and increased mortality as factors. The majority of those who completed the survey were doctors.

The researchers concluded: “Our results offer preliminary data that the Covid-19 pandemic has affected Parkinson’s disease patients’ access to regular medication.

“Covid-19 has diverted resources away from chronic conditions towards the fight against Covid-19 in many countries. Resource-poor countries seem to be disproportionately affected compared to their affluent counterparts.”


Read more:

Brazilian dance could improve mobility in people with Parkinson’s, study finds

#WomenAndParkinsons shortlisted for ‘Charity Content Campaign of the Year’

Go Back

Share this story

Comments


Related articles


Tom Isaacs tribute lead

Perspectives

Tributes paid to “inspirational” Tom Isaacs

Social media users around the world react to death of Tom Isaacs

READ MORE
a person having their blood pressure taken

Global update

Parkinson’s in the news: June

This month’s Parkinson’s disease news stories from around the globe

READ MORE
An older woman practices boxing with a trainer.

Health & Fitness

From Nordic walking to boxing: six sports for Parkinson’s disease

Find out how exercise can help manage symptoms

READ MORE